{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:47:59Z","timestamp":1790808479252,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04314-8","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T12:54:57Z","timestamp":1749732897000},"page":"157-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic plasmapheresis in the management of thyrotoxicosis: a-retrospective study with emphasis on critically ill patients"],"prefix":"10.1007","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-7326","authenticated-orcid":false,"given":"Ummu","family":"Mutlu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senem","family":"Dadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-6473","authenticated-orcid":false,"given":"Hulya","family":"Hacisahinogullari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5576-9496","authenticated-orcid":false,"given":"Yalin","family":"Iscan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9013-5237","authenticated-orcid":false,"given":"Gulsah","family":"Yenidunya Yalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-944X","authenticated-orcid":false,"given":"Nurdan","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-4764","authenticated-orcid":false,"given":"Ozlem","family":"Soyluk Selcukbiricik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9310-1278","authenticated-orcid":false,"given":"Sevgi","family":"Kalayoglu Besisik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0478-1193","authenticated-orcid":false,"given":"Ayse","family":"Kubat Uzum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"4314_CR1","doi-asserted-by":"publisher","unstructured":"D.S. Ross, H.B. Burch, D.S. Cooper et al., 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10), 1343\u20131421 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0229.","DOI":"10.1089\/thy.2016.0229"},{"key":"4314_CR2","doi-asserted-by":"publisher","unstructured":"P. Abraham, A. Avenell, S.C. McGeoch, L.F. Clark, J.S. Bevan, Antithyroid drug regimen for treating Graves\u2019 hyperthyroidism. Cochrane Database Syst. Rev. 2010, Cd003420 (2010). https:\/\/doi.org\/10.1002\/14651858.CD003420.pub4.","DOI":"10.1002\/14651858.CD003420.pub4"},{"key":"4314_CR3","doi-asserted-by":"publisher","unstructured":"L. Bartalena, F. Bogazzi, L. Chiovato et al., 2018 european thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur. Thyroid. J. 7(2), 55\u201366 (2018). https:\/\/doi.org\/10.1159\/000486957.","DOI":"10.1159\/000486957"},{"key":"4314_CR4","doi-asserted-by":"publisher","unstructured":"F. Otsuka, J.Y. Noh, T. Chino et al., Hepatotoxicity and cutaneous reactions after antithyroid drug administration. Clin. Endocrinol. 77(2), 310\u2013315 (2012). https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04365.x.","DOI":"10.1111\/j.1365-2265.2012.04365.x"},{"key":"4314_CR5","doi-asserted-by":"publisher","unstructured":"H. Nakamura, A. Miyauchi, N. Miyawaki, J. Imagawa, Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J. Clin. Endocrinol. Metab. 98(12), 4776\u20134783 (2013). https:\/\/doi.org\/10.1210\/jc.2013-2569.","DOI":"10.1210\/jc.2013-2569"},{"key":"4314_CR6","doi-asserted-by":"publisher","unstructured":"K. Ahmed, S. Rao, V. Simha, Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole. Endocr. Pract. 16(3), 449\u2013451 (2010). https:\/\/doi.org\/10.4158\/ep09304.Cr.","DOI":"10.4158\/ep09304.Cr"},{"key":"4314_CR7","doi-asserted-by":"publisher","unstructured":"N. Ozbey, S. Kalayoglu-Besisik, N. Gul et al., Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated. Int. J. Clin. Pract. 58(6), 554\u2013558 (2004). https:\/\/doi.org\/10.1111\/j.1368-5031.2004.00140.x.","DOI":"10.1111\/j.1368-5031.2004.00140.x"},{"key":"4314_CR8","doi-asserted-by":"publisher","unstructured":"V. Garla, K. Kovvuru, S. Ahuja et al., Severe hyperthyroidism complicated by agranulocytosis treated with therapeutic plasma exchange: case report and review of the literature. Case Rep. Endocrinol. 2018, 4135940 (2018). https:\/\/doi.org\/10.1155\/2018\/4135940.","DOI":"10.1155\/2018\/4135940"},{"key":"4314_CR9","doi-asserted-by":"publisher","unstructured":"I.Y. Simsir, M. Ozdemir, S. Duman et al., Therapeutic plasmapheresis in thyrotoxic patients. Endocrine 62(1), 144\u2013148 (2018). https:\/\/doi.org\/10.1007\/s12020-018-1661-x.","DOI":"10.1007\/s12020-018-1661-x"},{"key":"4314_CR10","doi-asserted-by":"publisher","unstructured":"O. Ozdemir Baser, Z. Cetin, M. Catak, D. Koseoglu, D. Berker, The role of therapeutic plasmapheresis in patients with hyperthyroidism. Transfus. Apher. Sci. 59(4), 102744 (2020). https:\/\/doi.org\/10.1016\/j.transci.2020.102744.","DOI":"10.1016\/j.transci.2020.102744"},{"key":"4314_CR11","doi-asserted-by":"crossref","unstructured":"F.S. Ashkar, R.B. Katims, W.M. Smoak 3rd, A.J. Gilson, Thyroid storm treatment with blood exchange and plasmapheresis. Jama 214(7), 1275\u20131279 (1970).","DOI":"10.1001\/jama.1970.03180070041007"},{"key":"4314_CR12","doi-asserted-by":"publisher","unstructured":"T. Moazezi, C.K. Koh, The use of plasmapheresis in a severe case of amiodarone-induced thyrotoxicosis. JCEM Case Rep. 1(6), luad123 (2023). https:\/\/doi.org\/10.1210\/jcemcr\/luad123.","DOI":"10.1210\/jcemcr\/luad123"},{"key":"4314_CR13","doi-asserted-by":"publisher","unstructured":"A. Azezli, T. Bayraktaroglu, S. Topuz, S. Kalayoglu-Besisik, Hyperthyroidism in molar pregnancy: Rapid preoperative preparation by plasmapheresis and complete improvement after evacuation. Transfus. Apher. Sci. 36(1), 87\u201389 (2007). https:\/\/doi.org\/10.1016\/j.transci.2006.05.017.","DOI":"10.1016\/j.transci.2006.05.017"},{"key":"4314_CR14","doi-asserted-by":"publisher","unstructured":"E. Adali, R. Yildizhan, A. Kolusari, M. Kurdoglu, N. Turan, The use of plasmapheresis for rapid hormonal control in severe hyperthyroidism caused by a partial molar pregnancy. Arch. Gynecol. Obstet. 279(4), 569\u2013571 (2009). https:\/\/doi.org\/10.1007\/s00404-008-0762-9.","DOI":"10.1007\/s00404-008-0762-9"},{"key":"4314_CR15","doi-asserted-by":"publisher","unstructured":"M. Keklik, L. Kaynar, M. Yilmaz et al., The results of therapeutic plasma exchange in patients with severe hyperthyroidism: a retrospective multicenter study. Transfus. Apher. Sci. 48(3), 327\u2013330 (2013). https:\/\/doi.org\/10.1016\/j.transci.2013.04.010.","DOI":"10.1016\/j.transci.2013.04.010"},{"key":"4314_CR16","doi-asserted-by":"publisher","unstructured":"L. Connelly-Smith, C.R. Alquist, N.A. Aqui et al., Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the american society for apheresis: the ninth special issue. J. Clin. Apher. 38(2), 77\u2013278 (2023). https:\/\/doi.org\/10.1002\/jca.22043.","DOI":"10.1002\/jca.22043"},{"key":"4314_CR17","doi-asserted-by":"publisher","unstructured":"S. Jha, S. Waghdhare, R. Reddi, P. Bhattacharya, Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis. Thyroid 22(12), 1283\u20131286 (2012). https:\/\/doi.org\/10.1089\/thy.2011.0353.","DOI":"10.1089\/thy.2011.0353"},{"key":"4314_CR18","unstructured":"S. Refetoff, in Thyroid Hormone Serum Transport Proteins. ed. by K.R. Feingold, B. Anawalt, M.R. Blackman, et al. (MDText.com, Inc., South Dartmouth (MA), 2000)"},{"key":"4314_CR19","doi-asserted-by":"publisher","unstructured":"T. Apayd\u0131n, O. Elbasan, D.G. Yavuz, Preoperative plasmapheresis experience in Graves\u2019 disease patients with anti-thyroid drug-induced hepatotoxicity. Transfus. Apher. Sci. 59(5), 102826 (2020). https:\/\/doi.org\/10.1016\/j.transci.2020.102826.","DOI":"10.1016\/j.transci.2020.102826"},{"key":"4314_CR20","doi-asserted-by":"publisher","unstructured":"W. Koziak, S. Dudek, Z. Putowski, F. Sanfilippo, M. Zawadka, Exploring the role of plasmapheresis prior to thyroidectomy in managing thyrotoxicosis: a comprehensive scoping review. Journal of Artificial Organs. (2024). https:\/\/doi.org\/10.1007\/s10047-024-01476-6","DOI":"10.1007\/s10047-024-01476-6"},{"key":"4314_CR21","doi-asserted-by":"publisher","unstructured":"T. Apaydin, D. Gogas Yavuz, Preoperative plasmapheresis in patients with Graves\u2019 disease intolerant to antithyroid drugs. Ther. Apher. Dial. 25(6), 877\u2013883 (2021). https:\/\/doi.org\/10.1111\/1744-9987.13639.","DOI":"10.1111\/1744-9987.13639"},{"key":"4314_CR22","doi-asserted-by":"publisher","unstructured":"\u015e Bahsi, U. Ant, N. Rustemova, F.O. \u00d6nder, \u00d6 Celik, Successful preoperative treatment with plasmapheresis of patients with hyperthyroidism. Turk. J. Endocrinol. Metab. 22(2), 113 (2018). https:\/\/doi.org\/10.25179\/tjem.2017-56533.","DOI":"10.25179\/tjem.2017-56533"},{"key":"4314_CR23","doi-asserted-by":"publisher","unstructured":"A. Ezer, K. Caliskan, A. Parlakgumus et al., Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J. Clin. Apher. 24(3), 111\u2013114 (2009). https:\/\/doi.org\/10.1002\/jca.20200.","DOI":"10.1002\/jca.20200"},{"key":"4314_CR24","doi-asserted-by":"publisher","unstructured":"J. Binimelis, L. Bassas, L. Marruecos et al., Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med. 13(1), 33\u201338 (1987). https:\/\/doi.org\/10.1007\/bf00263555.","DOI":"10.1007\/bf00263555"},{"key":"4314_CR25","doi-asserted-by":"publisher","unstructured":"J.H. Yeh, H.C. Chiu, Coagulation abnormalities in serial double-filtration plasmapheresis. J. Clin. Apher. 16(3), 139\u2013142 (2001). https:\/\/doi.org\/10.1002\/jca.1026.","DOI":"10.1002\/jca.1026"},{"key":"4314_CR26","doi-asserted-by":"publisher","unstructured":"M.A. Flaum, R.A. Cuneo, F.R. Appelbaum et al., The hemostatic imbalance of plasma-exchange transfusion. Blood 54(3), 694\u2013702 (1979). https:\/\/doi.org\/10.1182\/blood.V54.3.694.694.","DOI":"10.1182\/blood.V54.3.694.694"},{"key":"4314_CR27","doi-asserted-by":"publisher","unstructured":"L. Wood, P. Jacobs, The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels. J. Clin. Apher. 3(2), 124\u2013128 (1986). https:\/\/doi.org\/10.1002\/jca.2920030209.","DOI":"10.1002\/jca.2920030209"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04314-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:00:16Z","timestamp":1758772816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04314-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04314-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of xxxxx Faculty of Medicine. (Approval date 10.01.2025 and number 01). Informed consent was not obtained from the patients because patient data were collected from plasmapheresis unit data and patient records retrospectively.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}